A randomized, open label, clinical trial of the pharmacokinetics of azithromycin in serum, bronchial washings and lung tissue following a single dose of azithromycin sustained release (2 gram) or commercial azithromycin tablet (500 mg) to cancer patients that require lung resection
Latest Information Update: 11 Jun 2011
At a glance
- Drugs Azithromycin (Primary)
- Indications Bacterial infections; Respiratory tract infections
- Focus Pharmacokinetics
- Sponsors Pfizer
- 11 Apr 2008 New trial record.